EE320 Budget Impact Analysis of Implementing a 23-Valent Pneumococcal Polysaccharide Vaccine in the Brazilian National Immunization Program for Adults 60 Years Old

Brazil does not have pneumococcal vaccine as part of the older adults’ immunization schedule in National Immunization Program (NIP). This study aims to estimate the budget impact of implementing a single dose of 23-valent polysaccharide vaccine (PPSV23) into NIP for adults aged 60 years from the Brazilian public payer perspective.